ArticleBioengineering (Basel, Switzerland)2024
Dual and Multi-Target Cone-Beam X-ray Luminescence Computed Tomography Based on the DeepCB-XLCT Network.
Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
BACKGROUND AND
objectiveEmerging as a hybrid imaging modality, cone-beam X-ray luminescence computed tomography (CB-XLCT) has been developed using X-ray-excitable nanoparticles. In contrast to conventional bio-optical imaging techniques like bioluminescence tomography (BLT) and fluorescence molecular tomography (FMT), CB-XLCT offers the advantage of greater imaging depth while significantly reducing interference from autofluorescence and background fluorescence, owing to its utilization of X-ray-excited nanoparticles. However, due to the intricate excitation process and extensive light scattering within biological tissues, the inverse problem of CB-XLCT is fundamentally ill-conditioned.
methodsAn end-to-end three-dimensional deep encoder-decoder network, termed DeepCB-XLCT, is introduced to improve the quality of CB-XLCT reconstructions. This network directly establishes a nonlinear mapping between the distribution of internal X-ray-excitable nanoparticles and the corresponding boundary fluorescent signals. To improve the fidelity of target shape restoration, the structural similarity loss (SSIM) was incorporated into the objective function of the DeepCB-XLCT network. Additionally, a loss term specifically for target regions was introduced to improve the network's emphasis on the areas of interest. As a result, the inaccuracies in reconstruction caused by the simplified linear model used in conventional methods can be effectively minimized by the proposed DeepCB-XLCT method. RESULTS AND
conclusionsNumerical simulations, phantom experiments, and in vivo experiments with two targets were performed, revealing that the DeepCB-XLCT network enhances reconstruction accuracy regarding contrast-to-noise ratio and shape similarity when compared to traditional methods. In addition, the findings from the XLCT tomographic images involving three targets demonstrate its potential for multi-target CB-XLCT imaging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.